OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Organization: MD Anderson Cancer Center

1 Projects | 1 Researchers | $538,620 Invested

2016

MD Anderson Cancer Center

William Ray, PhD

Therapeutic Potential of Dual Leucine Zipper Kinase Inhibitors in Alzheimer's Disease

  • Funding Amount: $538,620
  • Organization Type: Academic/Nonprofit
  • Program: Drug Discovery
  • Target: Neuronal Regeneration and Repair
  • Status: Closed